Measurement of antibody titers against infectious viral diseases in patients with inflammatory bowel disease treated with immunosuppressive agents : a multicenter study

Measurement of antibody titers against infectious viral diseases in patients with inflammatory bowel disease treated with immunosuppressive agents : a multicenter study - Antibody titers against infectious viral diseases in immunocompromised IBD

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000039696

Enrollment

500

Registered

2020-03-05

Start date

2019-11-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn&#39

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with confirmed diagnosis of Crohn's disease or ulcerative colitis Patients who are or will be treated with immunosuppressive agents (prednisolone, thiopurine, methotrexate, anti-TNF agents, ustekinumab, tofacitinib, vedolizumab, etc.) Patients aged 20 or more (including patients aged 16 to under 20 with parental consent)

Exclusion criteria

Exclusion criteria: Patients without confirmed diagnosis of Crohn's disease or ulcerative colitis Patients under 16 years Patients judged as unsuitable for the participation by physicians

Design outcomes

Primary

Measure	Time frame
seronegative rates of infectious viral diseases (measles, mumps, rubella, varicella zoster, cytomegalovirus and Epstein-Barr virus)	—

Secondary

Measure	Time frame
seronegative rates of infectious viral diseases stratified according to disease type (Crohn's disease or ulcerative colitis), age, disease duration or type of immunosuppressive agents	—

Countries

Japan

Contacts

Public ContactHisashi Shiga

Tohoku University Hospital Division of Gastroenterology

shiga@med.tohoku.ac.jp022-717-7171

Outcome results